DuSCN-FusionNet: An Interpretable Dual-Channel Structural Covariance Fusion Framework for ADHD Classification Using Structural MRI
This work addresses the challenge of reliable neurobiological diagnosis for ADHD, offering an interpretable method to identify potential biomarkers, though it is incremental in improving classification accuracy.
The authors tackled ADHD classification from structural MRI by proposing an interpretable dual-channel framework that captures morphological relationships, achieving a mean balanced accuracy of 80.59% and an AUC of 0.778 on a specific dataset.
Attention Deficit Hyperactivity Disorder (ADHD) is a highly prevalent neurodevelopmental condition; however, its neurobiological diagnosis remains challenging due to the lack of reliable imaging-based biomarkers, particularly anatomical markers. Structural MRI (sMRI) provides a non-invasive modality for investigating brain alterations associated with ADHD; nevertheless, most deep learning approaches function as black-box systems, limiting clinical trust and interpretability. In this work, we propose DuSCN-FusionNet, an interpretable sMRI-based framework for ADHD classification that leverages dual-channel Structural Covariance Networks (SCNs) to capture inter-regional morphological relationships. ROI-wise mean intensity and intra-regional variability descriptors are used to construct intensity-based and heterogeneity-based SCNs, which are processed through an SCN-CNN encoder. In parallel, auxiliary ROI-wise variability features and global statistical descriptors are integrated via late-stage fusion to enhance performance. The model is evaluated using stratified 10-fold cross-validation with a 5-seed ensemble strategy, achieving a mean balanced accuracy of 80.59% and an AUC of 0.778 on the Peking University site of the ADHD-200 dataset. DuSCN-FusionNet further achieves precision, recall, and F1-scores of 81.66%, 80.59%, and 80.27%, respectively. Moreover, Grad-CAM is adapted to the SCN domain to derive ROI-level importance scores, enabling the identification of structurally relevant brain regions as potential biomarkers.